Betaherpes viral genes and their functions

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 204-230

  Mocarski, Edward S ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929273361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.016     Document Type: Chapter

References (309)

1. Abate, D. A., Watanabe, S., and Mocarski, E. S. (2004). Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the inter-feron response. J. Virol., 78, 10995-11006.
2. Adair, R., Douglas, E. R., Maclean, J. B. et al. (2002). The prod-ucts of human cytomegalovirus genes UL23, UL24, UL43 and US22 are tegument components. J. Gen. Virol., 83, 1315-1324.
3. Adair, R., Liebisch, G. W., and Colberg-Poley, A. M. (2003). Complex alternative processing of human cytomegalovirus UL37 pre-mRNA. J. Gen. Virol., 84, 3353-3358.
4. Agulnick, A. D., Thompson, J. R., Iyengar, S., Pearson, G., Ablashi, D., and Ricciardi, R. P. (1993). Identi?cation of a DNA-binding protein of human herpesvirus 6, a putative DNA polymerase stimulatory factor. J. Gen. Virol., 74(6), 1003-1009.
5. Ahn, J. H. and Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with ef?cient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology, 274, 39-55.
6. Ahn, J. H., Jang, W. J., and Hayward, G. S. (1999). The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol., 73, 10458-10471.
7. Akter, P., Cunningham, C., McSharry, B. P. et al. (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol., 84, 1117-1122.
8. Alderete, J. P., Child, S. J., and Geballe, A. P. (2001). Abundant early expression of gpUL4 from a human cytomegalovirus mutant lacking a repressive upstream open reading frame. J. Virol., 75, 7188-7192.
9. Anders, D. G. and Gibson, W. (1988). Location, transcript analysis, and partial nucleotide sequence of the cytomegalovirus gene encoding an early DNA-binding protein with similarities to ICP8 of herpes simplex virus type 1. J. Virol., 62, 1364-1372.
10. Anders, D. G., Kacica, M. A., Pari, G., and Punturieri, S. M. (1992). Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J. Virol., 66, 3373-3384.
11. Ansari, A. and Emery, V. C. (1999). The U69 gene of human her-pesvirus 6 encodes a protein kinase which can confer ganci-clovir sensitivity to baculoviruses. J. Virol., 73, 3284-3291.
12. Appleton, B. A., Loregian, A., Filman, D. J., Coen, D. M., and Hogle, J. M. (2004). The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol. Cell, 15, 233-244
13. Atalay, R., Zimmermann, A., Wagner, M. et al. (2002). Identi?cation and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J. Virol., 76, 8596-8608.
14. AuCoin, D. P., Smith, G. B., Meiering, C. D., and Mocarski, E. S.(2006). Betaherpesvirus-conserved cytomegalovirus tegument pro-tein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J. Virol., 80, 8199-8821.
15. Baek, M. C., Krosky, P. M., Pearson, A., and Coen, D. M. (2004). Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase. Virology, 324, 184-193.
16. Baldick, C. J., Jr. and Shenk, T. (1996). Proteins associated with puri-?ed human cytomegalovirus particles. J. Virol., 70, 6097-6105.
17. Baldick, C. J., Jr., Marchini, A., Patterson, C. E., and Shenk, T. (1997). Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infec-tious cycle. J. Virol., 71, 4400-4408.
18. Baldwin, B. R., Zhang, C. O., and Keay, S. (2000). Cloning and epi-tope mapping of a functional partial fusion receptor for human cytomegalovirus gH. J. Gen. Virol., 81, 27-35.
19. Barrasa, M. I., Harel, N. Y., and Alwine, J. C. (2005). The phos-phorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early pro-tein IE2/IEP86 affects temporal viral gene expression. J. Virol., 79, 1428-1437.
20. Battista, M. C., Bergamini, G., Boccuni, M. C., Campanini, F., Ripalti, A., and Landini, M. P. (1999). Expression and characteriza-tion of a novel structural protein of human cytomegalovirus, pUL25. J. Virol., 73, 3800-3809.
21. Baxter, M. K. and Gibson, W. (2001). Cytomegalovirus basic phos-phoprotein (pUL32) binds to capsids in vitro through its amino one-third. J. Virol., 75, 6865-6873.
22. Bechtel, J. T. and Shenk, T. (2002). Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J. Virol., 76, 1043-1050.
23. Biegalke, B. J., Lester, E., Branda, A., and Rana, R. (2004). Charac-terization of the human cytomegalovirus UL34 gene. J. Virol., 78, 9579-9583.
24. Billstrom, M. A., Lehman, L. A., and Worthen, S. G. (1999). Deple-tion of extracellular RANTES during human cytomegalovirus infection of endothelial cells. Am. J. Respir. Cell. Mol. Biol., 21, 163-167.
25. Blankenship, C. A. and Shenk, T. (2002). Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect. J. Virol., 76, 12290-12299.
26. Boehme, K. W., Singh, J., Perry, S. T., and Compton, T. (2004). Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J. Virol., 78, 1202-1211. Boehmer, P. E. and Nimonkar, A. V. (2003). Herpes virus replication. IUBMB Life, 55, 13-22
27. Bogner, E. (2002). Human cytomegalovirus terminase as a target for antiviral chemotherapy. Rev. Med. Virol., 12, 115-127.
28. Bogner, E., Radsak, K., and Stinski, M. F. (1998). The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has speci?c nuclease activity. J. Virol., 72, 2259-2264.
29. Bolovan-Fritts, C. A., and Wiedeman, J. A. (2002). Mapping the viral genetic determinants of endothelial cell tropism in human cytomegalovirus. J. Clin. Virol., 25 Suppl 2, S97-109.
30. Borst, E. M., Hahn, G., Koszinowski, U. H., and Messerle, M. (1999). Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial arti?cial chromosome in Escherichia coli: A new approach for construction of HCMV mutants. J. Virol., 73, 8320-8329.
31. Boyle, K. A., Pietropaolo, R. L., and Compton, T. (1999). Engage-ment of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell Biol., 19, 3607-3613.
32. Bresnahan, W. A. and Shenk, T. E. (2000). UL82 virion protein acti-vates expression of immediate early viral genes in human cytomegalovirus-infected cells Proc. Natl Acad. Sci. USA, 97, 14506-14511.
33. Britt, W. J. and Mach, M. (1996). Human cytomegalovirus glycopro-teins. Intervirology, 39, 401-412.
34. Britt, W. J., Jarvis, M., Seo, J. Y., Drummond, D., and Nelson, J. (2004). Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: Demonstration that pp28 (UL99) is essential for production of infectious virus. J. Virol., 78, 539-543.
35. Brown, J. M., Kaneshima, H., and Mocarski, E. S. (1995). Dra-matic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis., 171, 1599-1603.
36. Brune, W., Menard, C., Heesemann, J., and Koszinowski, U. H. (2001). A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science, 291, 303-305.
37. Buerger, I., Reefschlaeger, J., Bender, W. et al. (2001). A novel non-nucleoside inhibitor speci?cally targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J. Virol., 75, 9077-9086.
38. Caposio, P., Riera, L., Hahn, G., Landolfo, S., and Gribaudo, G.(2004). Evidence that the human cytomegalovirus 46-kDa UL72 pro-tein is not an active dUTPase but a late protein dispensable for replication in ?broblasts. Virology, 325, 264-276.
39. Casaday, R. J., Bailey, J. R., Kalb, S. R. et al. (2004). Assembly pro-tein precursor (pUL80.5 homolog) of simian cytomegalovirus is phosphorylated at a glycogen synthase kinase 3 site and its downstream “priming” site: Phosphorylation affects interac-tions of protein with itself and with major capsid protein. J. Virol., 78, 13501-13511.
40. Casarosa, P., Bakker, R. A., Verzijl, D. etal.(2001). Constitutivesignal-ing of the human cytomegalovirus-encoded chemokine recep-tor US28. J. Biol. Chem., 276, 1133-1137.
41. Casarosa, P., Gruijthuijsen, Y. K., Michel, D. et al. (2003). Constitu-tive signaling of the human cytomegalovirus-encoded recep-tor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. J. Biol. Chem., 278, 50010-50023.
42. Cavanaugh, V. J., Stenberg, R. M., Staley, T. L. et al. (1996). Murine cytomegalovirus with a deletion of genes spanning HindIII-J and-I displays altered cell and tissue tropism. J. Virol., 70, 1365-1374.
43. Cha, T. A., Tom, E., Kemble, G. W., Duke, G. M., Mocarski, E. S., and Spaete, R. R. (1996). Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol., 70, 78-83.
44. Chang, W. L., Baumgarth, N., Yu, D., and Barry, P. A. (2004). Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol., 78, 8720-8731.
45. Chee, M. S., Bankier, A. T., Beck, S. et al. (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol., 154, 125-170.
46. Child, S. J., Jarrahian, S., Harper, V. M., and Geballe, A. P. (2002). Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J. Virol., 76, 4912-4918.
47. Child, S. J., Hakki, M., De Niro, K. L., and Geballe, A. P. (2004). Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol., 78, 197-205.
48. Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., and Biron, K. K. (2004). Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir. J. Virol., 78, 7124-7130.
49. Colberg-Poley, A. M., Huang, L., Soltero, V. E., Iskenderian, A. C., Schumacher, R. F., and Anders, D. G. (1998). The acidic domain of pUL37 1 and gpUL37 plays a key role in transactivation of HCMV DNA replication gene promoter constructions Virology, 246, 400-408.
50. Colletti, K. S., Xu, Y., Cei, S. A., Tarrant, M., and Pari, G. S. (2004). Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of oriLyt-dependent DNA replication: Evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA repli-cation. J. Virol., 78, 9203-9214.
51. Colletti, K. S., Xu, Y., Yamboliev, I., and Pari, G. S. (2005). Human cytomegalovirus UL84 Is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H box family of proteins. J. Biol. Chem., 280, 11955-11960.
52. Compton, T. (2004). Receptors and immune sensors: The complex entry path of human cytomegalovirus. Trends Cell Biol., 14, 5-8.
53. Compton, T., Nepomuceno, R. R., and Nowlin, D. M. (1992). Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology, 191, 387-395.
54. Compton, T., Nowlin, D. M., and Cooper, N. R. (1993). Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology, 193, 834-841.
55. Compton, T., Kurt-Jones, E. A., Boehme, K. W. et al. (2003). Human cytomegalovirus activates in?ammatory cytokine responses via CD14 and toll-like receptor 2. J. Virol., 77, 4588-4596.
56. Conti, C., Cirone, M., Sgro, R., Altieri, F., Zompetta, C., and Faggioni, A. (2000). Early interactions of human herpesvirus 6 with lym-phoid cells: Role of membrane protein components and gly-cosaminoglycans in virus binding. J. Med. Virol., 62, 487-497
57. Courcelle, C. T., Courcelle, J., Prichard, M. N., and Mocarski, E. S. (2001). Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J. Virol., 75, 7592-7601
58. Dal Monte, P., Pignatelli, S., Zini, N. et al. (2002). Analysis of intracel-lular and intraviral localization of the human cytomegalovirus UL53 protein. J. Gen. Virol., 83, 1005-1012.
59. Dal Monte, P., Pignatelli, S., Rossini, G., and Landini, M. P. (2004). Genomic variants among human cytomegalovirus (HCMV) clinical isolates: The glycoprotein n (gN) paradigm. Hum. Immunol., 65, 387-394.
60. Dargan, D. J., Jamieson, F. E., MacLean, J., Dolan, A., Addison, C., and McGeoch, D. J. (1997). The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol., 71, 9833-9836.
61. Davison, A. J., Dolan, A., Akter, P. et al. (2003). The human cytomegalovirus genome revisited: Comparison with the chim-panzee cytomegalovirus genome. J. Gen. Virol., 84, 17-28.
62. Dewhurst, S., Dollard, S. C., Pellett, P. E., and Dambaugh, T. R. (1993). Identi?cation of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29. J. Virol., 67, 7680-7683.
63. Dhepakson, P., Mori, Y., Jiang, Y. B. et al. (2002). Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J. Gen. Virol., 83, 847-854.
64. Dittmer, A. and Bogner, E. (2005). Analysis of the quaternary struc-ture of the putative HCMV portal protein pUL104. Biochem-istry, 44, 759-765.
65. Dolan, A., Cunningham, C., Hector, R. D. et al. (2004). Genetic con-tent of wild-type human cytomegalovirus. J. Gen. Virol., 85, 1301-1312.
66. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999a). Human herpesvirus 6B genome sequence: Coding content and comparison with human her-pesvirus 6A. J. Virol., 73, 8040-8052.
67. Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N., and Pellett, P. E. (1999b). Human herpesvirus 6B genome sequence: Coding content and comparison with human her-pesvirus 6A. J. Virol., 73, 8040-8052.
68. Doniger, J., Muralidhar, S., and Rosenthal, L. J. (1999). Human cytomegalovirus and human herpesvirus 6 genes that trans-form and transactivate. Clin. Microbiol. Rev., 12, 367-382.
69. Dunn, C., Chalupny, N. J., Sutherland C. L. et al. (2003a). Human cytomegalovirus glycoprotein UL16 causes intracellu-lar sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med., 197, 1427-1439.
70. Dunn, W., Chou, C., Li, H. et al. (2003b). Functional pro?ling of a human cytomegalovirus genome. Proc. Natl Acad. Sci. USA, 100, 14223-14228.
71. Dykes, C., Chan, H., Krenitsky, D. M., and Dewhurst, S. (1997). Strin-gent structural and sequence requirements of the human her-pesvirus 6B lytic-phase origin of DNA replication. J. Gen. Virol., 78(5), 1125-1129.
72. Evers, D. L., Wang, X., and Huang, E. S. (2004). Cellular stress and sig-nal transduction responses to human cytomegalovirus infec-tion. Microbes Infect. 6, 1084-1093.
73. Feire, A. L., Koss, H., and Compton, T. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl Acad. Sci. USA, 101, 15470-15475.
74. Flebbe-Rehwaldt, L. M., Wood, C., and Chandran, B. (2000). Char-acterization of transcripts expressed from human herpesvirus 6A strain GS immediate-early region B U16-U17 open reading frames. J. Virol., 74, 11040-11054.
75. Fortunato, E. A., Sanchez, V., Yen, J. Y., and Spector, D. H. (2002). Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J. Virol., 76, 5369-5379.
76. Fraile-Ramos, A., Pelchen-Matthews, A., Kledal, T. N., Browne, H., Schwartz, T. W., and Marsh, M. (2002). Localization of HCMV UL33 and US27 in endocytic compartments and viral mem-branes. Traf?c, 3, 218-232.
77. French, C., Menegazzi, P., Nicholson, L., Macaulay, H., DiLuca, D., and Gompels, U. A. (1999). Novel, nonconsensus cellular splic-ing regulates expression of a gene encoding a chemokine-like protein that shows high variation and is speci?c for human herpesvirus 6. Virology, 262, 139-151.
78. Furman, M. H., Dey, N., Tortorella, D., and Ploegh, H. L. (2002). The human cytomegalovirus US10 gene product delays traf?cking of major histocompatibility complex class I molecules. J. Virol., 76, 11753-11756.
79. Gao, J. L. and Murphy, P. M. (1994). Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem., 269, 28539-28542.
80. Gao, M., Robertson, B. J., McCann, P. J. et al. (1998). Functional conservations of the alkaline nuclease of herpes simplex type 1 and human cytomegalovirus. Virology, 249, 460-470.
81. Gawn, J. M. and Greaves, R. F. (2002). Absence of IE1 p72 pro-tein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J. Virol., 76, 4441-4455.
82. Gebert, S., Schmolke, S., Sorg, G., Floss, S., Plachter, B., and Stamminger, T. (1997). The UL84 protein of human cyto-megalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J. Virol., 71, 7048-7060.
83. Gerna, G., Percivalle, E., Sarasini, A., Baldanti, F., Campanini, G., and Revello, M. G. (2003). Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J. Gen. Virol., 84, 1431-1436.
84. Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W., and Ploegh, H. L. (2001). Virus subversion of immunity: A structural perspec-tive. Curr. Opin. Immunol., 13, 442-450.
85. Gibson, W. (1996). Structure and assembly of the virion. Intervirol-ogy, 39, 389-400.
86. Gibson, W., Baxter, M. K., and Clopper, K. S. (1996). Cytomegalovirus “missing” capsid protein identi?ed as heat-aggregable prod-uct of human cytomegalovirus UL46. J. Virol., 70, 7454-7461.
87. Goldmacher, V. S., Bartle, L. M., Skaletskaya, A. et al. (1999). A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA, 96, 12536-12541.
88. Gompels, U. A. and Macaulay, H. A. (1995). Characterization of human telomeric repeat sequences from human herpesvirus 6 and relationship to replication. J. Gen. Virol., 76, 451-458.
89. Gompels, U. A., Nicholas, J., Lawrence, G. et al. (1995). The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology, 209, 29-51.
90. Gravel, A., Tomoiu, A., Cloutier, N., Gosselin, J., and Flamand, L. (2003). Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology, 308, 340-353.
91. Greaves, R. F. and Mocarski, E. S. (1998). Defective growth correlates with reduced accumulation of a viral DNA replication protein after low multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol., 72, 366-379.
92. Greijer, A. E., Dekkers, C. A., and Middeldrop, J. M. (2000). Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J. Virol., 74, 9078-9082.
93. Grzimek, N. K., Podlech, J., Steffens, H. P., Holtappels, R., Schmalz, S., and Reddehase, M. J. (1999). In vivo replication of recombinant murine cytomegalovirus driven by the paralo-gous major immediate-early promoter-enhancer of human cytomegalovirus. J. Virol., 73, 5043-5055.
94. Guo, Y. W. and Huang, E. S. (1993). Characterization of a struc-turally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J. Virol., 67, 2043-2054.
95. Hahn, G., Khan, H., Baldanti, F., Koszinowski, U. H., Revello, M. G., and Gerna, G. (2002). The human cytomegalovirus ribonu-cleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol., 76, 9551-9555.
96. Hahn, G., Jarosch, M., Wang, J. B., Berbes, C., and McVoy, M. A. (2003). Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombi-nant virus construction. J. Virol. Methods, 107, 185-194.
97. Hahn, G., Revello, M. G., Patrone, M. et al. (2004). Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol., 78, 10023-10033.
98. Hanson, L. K., Slater, J. S., Karabekian, Z., Ciocco-Schmitt, G., and Campbell, A. E. (2001). Products of US22 genes M140 and M141 confer ef?cient replication of murine cytomegalovirus in macrophages and spleen. J. Virol., 75, 6292-6302.
99. Hayajneh, W. A., Colberg-Poley, A. M., Skaletskaya, A. et al. (2001a). The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology, 279, 233-240.
100. Hayajneh, W. A., Contopoulos-Ioannidis, D. G., Lesperance, M. M., Venegas, A. M., and Colberg-Poley, A. M. (2001b). The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is impor-tant for transactivation. J. Gen. Virol., 82, 1569-1579.
101. Hayashi, M. L., Blankenship, C., and Shenk, T. (2000). Human cytomegalovirus UL69 protein is required for ef?cient accu-mulation of infected cells in the G1 phase of the cell cycle Proc. Natl Acad. Sci. USA, 97, 2692-2696.
102. Hegde, N. R., Tomazin, R. A., Wisner, T. W. et al. (2002). Inhibi-tion of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: A novel mechanism for evading major histocompatibility complex class II antigen pre-sentation. J. Virol., 76, 10929-10941.
103. Heider, J. A., Bresnahan, W. A., and Shenk, T. E. (2002). Construc-tion of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein. Proc. Natl Acad. Sci. USA, 99, 3141-3146.
104. Hertel, L. and Mocarski, E. S. (2004). Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J. Virol., 78, 11988-12011.
105. Hertel, L., Lacaille, V. G., Strobl, H., Mellins, E. D., and Mocarski, E. S. (2003). Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol., 77, 7563-7574.
106. Hewitt, E. W., Gupta, S. S., and Lehner, P. J. (2001). The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J., 20, 387-396.
107. Hitomi, S., Kozuka-Hata, H., Chen, Z., Sugano, S., Yamaguchi, N., and Watanabe, S. (1997). Human cytomegalovirus open reading frame UL11 encodes a highly polymorphic protein expressed on the infected cell surface. Arch. Virol., 142, 1407-1427.
108. Hobom, U., Brune, W., Messerle, M., Hahn, G., and Koszinowski, U. H. (2000). Fast screening procedures for random transpo-son libraries of cloned herpesvirus genomes: Mutational anal-ysis of human cytomegalovirus envelope glycoprotein genes. J. Virol., 74, 7720-7729.
109. Hofmann, H., Sindre, H., and Stamminger, T. (2002). Func-tional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human daxx. J. Virol., 76, 5769-5783.
110. Huang, L., Zhu, Y., and Anders, D. G. (1996). The variable 3 ends of a human cytomegalovirus oriLyt transcript (SRT) overlap an essential, conserved replicator element. J. Virol., 70, 5272-5281.
111. Huber, M. T. and Compton, T. (1998). The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol., 72, 8191-8197.
112. Huber, M. T. and Compton T. (1999). Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycopro-tein envelope complex of human cytomegalovirus. J. Virol., 73, 3886-3892.
113. Huber, M. T., Tomazin, R., Wisner, T., Boname, J., and Johnson, D. C. (2002). Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J. Virol., 76, 5748-5758.
114. Hudson, A. W., Howley, P. M., and Ploegh, H. L. (2001). A human herpesvirus 7 glycoprotein, U21, diverts major histocompat-ibility complex class I molecules to lysosomes. J. Virol., 75, 12347-12358.
115. Ihara, S., Takekoshi, M., Mori, N., Sakuma, S., Hashimoto, J., and Watanabe, Y. (1994). Identi?cation of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity. Arch. Virol., 137, 263-275.
116. Inoue, N. and Pellett, P. E. (1995). Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence. J. Virol., 69, 4619-4627.
117. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N., and Yamanishi, K. (1998). Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 72, 6104-6112.
118. Ishov, A. M., Vladimirova, O. V., and Maul, G. G. (2002). Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J. Virol., 76, 7705-7712.
119. Iskenderian, A. C., Huang, L., Reilly, A., Stenberg, R. M., and Anders, D. G. (1996). Four of eleven loci required for transient comple-mentation of human cytomegalovirus DNA replication coop-erate to activate expression of replication genes. J. Virol., 70, 383-392.
120. Jahn, G., Stenglein, S., Riegler, S., Einsele, H., and Sinzger, C. (1999). Human cytomegalovirus infection of immature dendritic cells and macrophages. Intervirology, 42, 365-372.
121. Janzen, D. M., Frolova, L., and Geballe, A. P. (2002). Inhibition of translation termination mediated by an interaction of eukary-otic release factor 1 with a nascent peptidyl-tRNA. Mol. Cell Biol., 22, 8562-8570.
122. Jarvis, M. A., Jones, T. R., Drummond, D. D. et al. (2004). Phos-phorylation of human cytomegalovirus glycoprotein B (gB) at the acidic cluster casein kinase 2 site (Ser900) is required for localization of gB to the trans-Golgi network and ef?cient virus replication. J. Virol., 78, 285-293.
123. Johnson, R. A., Huong, S. M., and Huang, E. S. (2000). Activa-tion of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: A novel mechanism for activation of p38. J. Virol., 74, 1158-1167.
124. Johnson, R. A., Wang, X., Ma, X. L., Huong, S. M., and Huang, E. S. (2001). Human cytomegalovirus up-regulates the phos-phatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol., 75, 6022-6032.
125. Jones, T. R. and Lee, S. W. (2004). An acidic cluster of human cytomegalovirus UL99 tegument protein is required for traf-?cking and function. J. Virol., 78, 1488-1502.
126. Kahl, M., Siegel-Axel, D., Stenglein, S., Jahn, G., and Sinzger, C. (2000). Ef?cient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol., 74, 7628-7635.
127. Kalejta, R. F. and Shenk, T. (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl Acad. Sci. USA, 100, 3263-3268.
128. Kari, B. and Gehrz, R. (1993). Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol., 74, 255-264.
129. Kattenhorn, L. M., Mills, R., Wagner, M. et al. (2004). Identi?cation of proteins associated with murine cytomegalovirus virions. J. Virol., 78, 1187-1197.
130. Kawaguchi, Y., Kato, K., Tanaka, M., Kanamori, M., Nishiyama, Y., and Yamanashi, Y. (2003). Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J. Virol., 77, 2359-2368.
131. Kaye, J. F., Gompels, U. A., and Minson, A. C. (1992). Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J. Gen. Virol., 73, 2693-2698.
132. Kemble, G. W., and Mocarski, E. S. (1989). A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J. Virol., 63, 4715-4728.
133. Kemble, G. W., McCormick, A. L., Pereira, L., and Mocarski, E. S. (1987). A cytomegalovirus protein with properties of herpes simplex virus ICP8: Partial puri?cation of the polypeptide and map position of the gene. J. Virol., 61, 3143-3151.
134. Kim, K., Trang, P., Umamoto, S., Hai, R., and Liu, F. (2004). RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins. Nucl. Acids Res., 32, 3427-3434.
135. Kledal, T. N., Rosenkilde, M. M., and Schwartz, T. W. (1998). Selec-tive recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett., 441, 209-214.
136. Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., and Drach, J. C. (2003). Resistance of human cytomegalovirus to the benz-imidazole L-ribonucleoside maribavir maps to UL27. J. Virol., 77, 11499-11506.
137. Komazin, G., Townsend, L. B., and Drach, J. C. (2004). Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides. J. Virol., 78, 710-715.
138. Kondo, K., Xu, J., and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive indi-viduals. Proc. Natl Acad. Sci. USA, 93, 11137-11142.
139. Kondo, K., Kondo, T., Shimada, K., Amo, K., Miyagawa, H., and Yamanishi, K. (2002a). Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J. Med. Virol., 67, 364-369.
140. Kondo, K., Shimada, K., Sashihara, J., Tanaka-Taya, K., and Yaman-ishi, K. (2002b). Identi?cation of human herpesvirus 6 latency-associated transcripts. J. Virol., 76, 4145-4151.
141. Kondo, K., Nozaki, H., Shimada, K., and Yamanishi, K. (2003a). Detection of a gene cluster that is dispensable for human her-pesvirus 6 replication and latency. J. Virol., 77, 10719-10724.
142. Kondo, K., Sashihara, J., Shimada, K. et al. (2003b). Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6. J. Virol., 77, 2258-2264.
143. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., and Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA, 97, 1695-1700.
144. Krosky, P. M., Underwood, M. R., Turk, S. R. et al. (1998). Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J. Virol., 72, 4721-4728.
145. Krosky, P. M., Ptak, R. G., Underwood, M. R., Biron, K. K., Townsend, L. B., and Drach, J. C. (2000). Differences in DNA packag-ing genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and Towne. Antivir Chem Chemother, 11, 349-352
146. Krosky, P. M., Baek, M. C., and Coen, D. M. (2003a). The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol., 77, 905-914.
147. Krosky, P. M., Baek, M. C., Jahng, W. J. et al. (2003b). The human cytomegalovirus UL44 protein is a substrate for the UL97 pro-tein kinase. J. Virol., 77, 7720-7727.
148. Krug, L. T., Inoue, N., and Pellett, P. E. (2001). Differences in DNA binding speci?city among Roseolovirus origin binding pro-teins. Virology, 288, 145-153.
149. Lai, L. and Britt, W. J. (2003). The interaction between the major capsid protein and the smallest capsid protein of human cytomegalovirus is dependent on two linear sequences in the smallest capsid protein. J. Virol., 77, 2730-2735.
150. Landini, M. P., Lazzarotto, T., Xu, J., Geballe, A. P., and Mocarski, E. S. (2000). Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts Biol. Blood Marrow Transpl., 6, 100-108.
151. LaPierre, L. A. and Biegalke, B. J. (2001). Identi?cation of a novel transcriptional repressor encoded by human cytomegalovirus. J. Virol., 75, 6062-6069.
152. Lee, H. R. and Ahn, J. H. (2004). Sumoylation of the major immediate-early IE2 protein of human cytomegalovirus Towne strain is not required for virus growth in cultured human ?broblasts. J. Gen. Virol., 85, 2149-2154.
153. Lembo, D., Donalisio, M., Hofer, A. et al. (2004). The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J. Virol., 78, 4278-4288.
154. Li, J., Yamamoto, T., Ohtsubo, K., Shirakata, M., and Hirai, K. (1999). Major product pp43 of human cytomegalovirus U(L)112-113 gene is a transcriptional coactivator with two functionally dis-tinct domains. Virology, 260, 89-97.
155. Lilley, B. N., Ploegh, H. L., and Tirabassi, R. S. (2001). Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol., 75, 11218-11221.
156. Lin, K. and Ricciardi, R. P. (1998). The 41-kDa protein of human herpesvirus 6 speci?cally binds to viral DNA polymerase and greatly increases DNA synthesis. Virology, 250, 210-219.
157. Lischka, P., Rosorius, O., Trommer, E., and Stamminger, T. (2001). A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69. EMBO J., 20, 7271-7283.
158. Littler, E., Lawrence, G., Liu, M. Y., Barrell, B. G., and Arrand, J. R. (1990). Identi?cation, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J. Virol., 64, 714-722.
159. Liu, B. and Stinski, M. F. (1992). Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol., 66, 4434-4444.
160. Liu, Y. and Biegalke, B. J. (2002). The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol., 76, 2460-2468.
161. Lockridge, K. M., Zhou, S. S., Kravitz, R. H. et al. (2000). Primate cytomegaloviruses encode and express an IL-10-like protein Virology, 268, 272-280.
162. Lopper, M. and Compton, T. (2004). Coiled-coil domains in gly-coproteins B and H are involved in human cytomegalovirus membrane fusion. J. Virol., 78, 8333-8341.
163. Loregian, A., Appleton, B. A., Hogle, J. M., and Coen, D. M. (2004a). Residues of human cytomegalovirus DNA polymerase cat-alytic subunit UL54 that are necessary and suf?cient for inter-action with the accessory protein UL44. J. Virol., 78, 158-167.
164. Loregian, A., Appleton, B. A., Hogle, J. M., and Coen, D. M. (2004b). Speci?c residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit. J. Virol., 78, 9084-9092.
165. Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berne-man, Z. N., and Gallo, R. C. (1994). CD4 is a critical compo-nent of the receptor for human herpesvirus 7: Interference with human immunode?ciency virus. Proc. Natl Acad. Sci. USA, 91, 3872-3876.
166. Luttichau, H. R., Clark-Lewis, I., Jensen, P. O., Moser, C., Gerstoft, J., and Schwartz, T. W. (2003). A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J. Biol. Chem., 278, 10928-10933.
167. Mach, M., Kropff, B., Dal Monte, P., and Britt, W. (2000). Com-plex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73) J. Virol., 74, 11881-11892.
168. Mach, M., Kropff, B., Kryzaniak, M., and Britt, W. (2005). Complex formation by glycoproteins M and N of human cytomegalovirus: Structural and functional aspects. J. Virol., 79, 2160-2170.
169. Maidji, E., Tugizov, S., Abenes, G., Jones, T., and Pereira, L. (1998). A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colo-calizes with the cytoskeletal proteins E-cadherin and F-actin. J. Virol., 72, 5717-5727.
170. Manichanh, C., Olivier-Aubron, C., Lagarde, J. P. et al. (2001). Selec-tion of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J. Gen. Virol., 82, 2767-2776.
171. Manning, W. C., Stoddart, C. A., Lagenaur, L. A., Abenes, G. B., and Mocarski, E. S. (1992). Cytomegalovirus determinant of repli-cation in salivary glands. J. Virol., 66, 3794-3802.
172. Marchini, A., Liu, H., and Zhu, H. (2001). Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol., 75, 1870-1878.
173. Masse, M. J., Karlin, S., Schachtel, G. A., and Mocarski, E. S. (1992). Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc. Natl Acad. Sci. USA, 89, 5246-5250.
174. Masse, M. J., Messerle, M., and Mocarski, E. S. (1997). The location and sequence composition of the replicator (orilyst) murine cytomegalovirus. Virology, 230, 350-360.
175. McCormick, A. L., Skaletskaya, A., Barry, P. A., Mocarski, E. S., and Goldmacher, V. S. (2003). Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. Virology, 316, 221-233.
176. McCormick, A. L., Meiring, C. D., Smith, G. D., and Mocarskhi, E. S. (2005). Mitochondrial cell death supprenors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J. Virol., 79, 12205-12217.
177. McMahon, T. P. and Anders, D. G. (2002). Interactions between human cytomegalovirus helicase-primase proteins. Virus Res., 86, 39-52.
178. Melnychuk, R. M., Streblow, D. N., Smith, P. P., Hirsch, A. J., Pancheva, D., and Nelson, J. A. (2004). Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J. Virol., 78, 8382-8391.
179. Menard, C., Wagner, M., Ruzsics, Z. et al. (2003). Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol., 77, 5557-5570.
180. Menegazzi, P., Galvan, M., Rotola, A., Ravaioli, T., Gonelli, A., Cassai, E., and Di Luca, D. (1999). Temporal mapping of transcripts in human herpesvirus-7. J. Gen. Virol., 80(10), 2705-2712.
181. Menotti, L., Mirandola, P., Locati, M., and Campadelli-Fiume, G. (1999). Traf?cking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 geneinvolvesacell-speci?cfunctionpresentin Tlymphocytes. J. Virol., 73, 325-333.
182. Mettenleiter, T. C. (2004). Budding events in herpesvirus morpho-genesis. Virus Res., 106, 167-180.
183. Michel, D. and Mertens, T. (2004). The UL97 protein kinase of human cytomegalovirus and homologues in other her-pesviruses: Impact on virus and host. Biochim. Biophys. Acta, 1697, 169-180.
184. Michel, D., Milotic, I., Wagner, M. et al. (2005). The human cytomegalovirus UL78 gene is highly conserved among clini-cal isolates, but is dispensable for replication in ?broblasts and a renal artery organ-culture system. J. Gen. Virol., 86, 297-306.
185. Milne, R. S., Paterson, D. A., and Booth, J. C. (1998). Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without. J. Gen. Virol., 79, 855-865.
186. Milne, R. S., Mattick, C., Nicholson, L., Devaraj, P., Alcami, A., and Gompels, U. A. (2000). RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J. Immunol., 164, 2396-2404.
187. Mirandola, P., Menegazzi, P., Merighi, S., Ravaioli, T., Cassai, E., and Di Luca, D. (1998). Temporal mapping of transcripts in her-pesvirus 6 variants. J. Virol., 72, 3837-3844.
188. Misaghi, S., Sun, Z. Y., Stern, P., Gaudet, R., Wagner, G., and Ploegh, H. (2004). Structural and functional analysis of human cytomegalovirus US3 protein. J. Virol., 78, 413-423.
189. Mocarski, E. S. (2002). Immunomodulation by cytomegaloviruses: Manipulative strategies beyond evasion. Trends Microbiol., 10, 332-339.
190. Mocarski, E. S., Jr. (2004). Immune escape and exploitation strate-gies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system. Cell Microbiol., 6, 707-717.
191. Mocarski, E. S., Liu, A. C., and Spaete, R. R. (1987). Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J. Gen. Virol., 68, 2223-2230.
192. Mocarski, E. S., Bonyhadi, M., Salimi, S., McCune, J. M., and Kaneshima, H. (1993). Human cytomegalovirus in a SCID-hu mouse: Thymic epithelial cells are prominent targets of viral replication. Proc. Natl Acad. Sci. USA, 90, 104-108
193. Mocarski, E. S., Kemble, G. W., Lyle, J. M., and Greaves, R. F. (1996). A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoreg-ulation. Proc. Natl Acad. Sci. USA, 93, 11321-11326.
194. Mocarski, E. S., Prichard, M. N., Tan, C. S., and Brown, J. M. (1997). Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology, 239, 169-175.
195. Mocarski, E.S., Hahn, G., White, K.L., Xu, J. et al. (2005) Myeloid cell recruitment and function in pathogenesis and latency. In Cytomegaloviruses: Molecular Biology and Immunology, ed. M. J. Reddehase, Hethersett, Norfolk. UK: Horizon Scienti?c Press. (in press)
196. Morello, C. S., Cranmer, L. D., and Spector, D. H. (1999). In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83). J. Virol., 73, 7678-7693.
197. Mori, Y., Seya, T., Huang, H. L., Akkapaiboon, P., Dhepakson, P., and Yamanishi, K. (2002). Human herpesvirus 6 variant A, but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, C046. J. Virol., 76, 6750-6761.
198. Mori, Y., Akkapaiboon, P., Yang, X., and Yamanishi, K. (2003a). The human herpesvirus 6 U100 gene product is the third compo-nent of the gH-gL glycoprotein complex on the viral envelope. J. Virol., 77, 2452-2458.
199. Mori, Y., Yang, X., Akkapaiboon, P., Okuno, T., and Yamanishi, K. (2003b). Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J. Virol., 77, 4992-4999.
200. Mori, Y., Akkapaiboon, P., Yonemoto, S. et al. (2004). Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J. Virol., 78, 4609-4616.
201. Mukai, T., Isegawa, Y., and Yamanishi, K. (1995). Identi?cation of the major capsid protein gene of human herpesvirus 7. Virus Res., 37, 55-62.
202. Muranyi, W., Haas, J., Wagner, M., Krohne, G., and Koszinowski, U. H. (2002). Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science, 297, 854-857.
203. Nakano, K., Tadagaki, K., Isegawa, Y., Aye, M. M., Zou, P., and Yaman-ishi, K. (2003). Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol., 77, 8108-8115.
204. Navarro, D., Paz, P., Tugizov, S., Topp, K., La Vail, J., and Pereira, L. (1993). Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology, 197, 143-158.
205. Neipel, F., Ellinger, K., and Fleckenstein, B. (1992). Gene for the major antigenic structural protein (p100) of human her-pesvirus 6. J. Virol., 66, 3918-3924.
206. Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J. (1993). Molecular cloning, functional expression, and signaling char-acteristics of a C-C chemokine receptor. Cell, 72, 415-425.
207. Nevels, M., Paulus, C., and Shenk, T. (2004). Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc. Natl Acad. Sci. USA, 101, 17234-17239.
208. Neyts, J., Snoeck, R., Schols, D. et al. (1992). Sulfated polymers inhibit the interaction of human cytomegalovirus with cell sur-face heparan sulfate. Virology, 189, 48-58.
209. Nicholas, J. (1996). Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J. Virol., 70, 5975-5989.
210. Nikolaou, K., Varinou, L., Inoue, N., and Arsenakis, M. (2003). Iden-ti?cation and characterization of gene products of ORF U90/89 of human herpesvirus 6. Acta Virol., 47, 17-26.
211. Ogawa-Goto, K., Irie, S., Omori, A. et al. (2002). An endoplas-mic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegu-ment protein encoded by UL48. J. Virol., 76, 2350-2362.
212. Ogawa-Goto, K., Tanaka, K., Gibson, W. et al. (2003). Micro-tubule network facilitates nuclear targeting of human cytomegalovirus capsid. J. Virol., 77, 8541-8547.
213. Oien, N. L., Thomsen, D. R., Wathen, M. W., Newcomb, W. W., Brown, J. C., and Homa, F. L. (1997). Assembly of herpes simplex virus capsids using the human cytomegalovirus scaffold protein: Critical role of the C terminus. J. Virol., 71, 1281-1291.
214. Papanikolaou, E., Kouvatsis, V., Dimitriadis, G., Inoue, N., and Arse-nakis, M. (2002). Identi?cation and characterization of the gene products of open reading frame U86/87 of human her-pesvirus 6. Virus Res., 89, 89-101.
215. Pari, G. S. and Anders, D. G. (1993). Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol., 67, 6979-6988.
216. Patrone, M., Percivalle, E., Secchi, M. et al. (2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and in?uences virus growth at low multiplicities of infection. J. Gen. Virol., 84, 3359-3370.
217. Patterson, C. E. and Shenk, T. (1999). Human cytomegalovirus UL36 protein is dispensable for viral replication in cultured cells. J. Virol., 73, 7126-7131.
218. Penfold, M. E. and Mocarski, E. S. (1997). Formation of cytomegalovirus DNA replication compartments de?ned by localization of viral proteins and DNA synthesis. Virology, 239, 46-61.
219. Penfold, M. E., Dairaghi, D. J., Duke, G. M. et al. (1999). Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl Acad. Sci. USA, 96, 9839-9844.
220. Pizzorno, M. C., Mullen, M. A., Chang, Y. N., and Hayward, G. S. (1991). The functionally active IE2 immediate-early regula-tory protein of human cytomegalovirus is an 80-kilodalton polypeptide that contains two distinct activator domains and a duplicated nuclear localization signal. J. Virol., 65, 3839-3852.
221. Plafker, S. M. and Gibson, W. (1998). Cytomegalovirus assem-bly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein. J. Virol., 72, 7722-7732
222. Prichard, M. N., Duke, G. M., and Mocarski, E. S. (1996). Human cytomegalovirus uracil DNA glycosylase is required for the nor-mal temporal regulation of both DNA synthesis and viral repli-cation. J. Virol., 70, 3018-3025.
223. Prichard, M. N., Jairath, S., Penfold, M. E., St Jeor, S., Bohlman, M. C., and Pari, G. S. (1998). Identi?cation of persistent RNA-DNA hybrid structures within the origin of replication of human cytomegalovirus. J. Virol., 72, 6997-7004.
224. Prichard, M. N., Gao, N., Jairath, S. et al. (1999). A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication de?ciency. J. Virol., 73, 5663-5670.
225. Prichard, M. N., Penfold, M. E., Duke, G. M., Spaete, R. R., and Kem-ble, G. W. (2001). A review of genetic differences between lim-ited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol., 11, 191-200.
226. Reboredo, M., Greaves, R. F., and Hahn, G. (2004). Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected ?broblasts against virus-induced apoptosis and are required for ef?cient virus replication. J. Gen. Virol., 85, 3555-3567.
227. Reid, G. G., Ellsmore, V., and Stow, N. D. (2003). An analysis of the requirements for human cytomegalovirus oriLyt-dependent DNA synthesis in the presence of the herpes simplex virus type 1 replication fork proteins. Virology, 308, 303-316.
228. Reinhardt, J., Smith, G. B., Himmelheber, C. T., Azizkhan-Clifford, J., and Mocarski, E. S. (2005). The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication. J. Virol., 79, 225-233.
229. Riegler, S., Hebart, H., Einsele, H., Brossart, P., Jahn, G., and Sinzger, C. (2000). Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol., 81, 393-399.
230. Romanowski, M. J. and Shenk, T. (1997). Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol., 71, 1485-1496.
231. Romanowski, M. J., Garrido-Guerrero, E., and Shenk, T. (1997). pIRS1 and pTRS1 are present in human cytomegalovirus viri-ons. J. Virol., 71, 5703-5705.
232. Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E., and Di Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc. Natl Acad. Sci. USA, 95, 13911-13916.
233. Sampaio, K. L., Cavignac, Y., Stierhof, Y. D., and Sinzger, C. (2005). Human cytomegalovirus labeled with green ?uorescent pro-tein for live analysis of intracellular particle movements. J. Virol., 79, 2754-2767.
234. Sanchez, V., Greis, K. D., Sztul, E., and Britt, W. J. (2000a). Accu-mulation of virion tegument and envelope proteins in a sta-ble cytoplasmic compartment during human cytomegalovirus replication: Characterization of a potential site of virus assem-bly J. Virol., 74, 975-986.
235. Sanchez, V., Sztul, E., and Britt, W. J. (2000b). Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic com-partment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment. J. Virol., 74, 3842-3851.
236. Sanchez, V., Clark, C. L., Yen, J. Y., Dwarakanath, R., and Spector, D. H. (2002). Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J. Virol., 76, 2973-2989.
237. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A., and Lusso, P. (1999). CD46 is a cellular receptor for human herpesvirus 6. Cell, 99, 817-827.
238. Santoro, F., Greenstone, H. L., Insinga, A. et al. (2003). Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem., 278, 25964-25969.
239. Sarisky, R. T. and Hayward, G. S. (1996). Evidence that the UL84 gene product of human cytomegalovirus is essential for pro-moting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J. Virol., 70, 7398-7413.
240. Saverino, D., Ghiotto, F., Merlo, A. et al. (2004). Speci?c recog-nition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol., 172, 5629-5637.
241. Scheffczik, H., Savva, C. G., Holzenburg, A., Kolesnikova, L., and Bogner, E. (2002). The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. Nucl. Acids Res., 30, 1695-1703.
242. Schierling, K., Stamminger, T., Mertens, T., and Winkler, M. (2004). Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J. Virol., 78, 9512-9523.
243. Schierling, K., Buser, C., Mertens, T., and Winkler, M. (2005). Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol., 79, 3084-3096.
244. Scholz, B., Rechter, S., Drach, J. C., Townsend, L. B., and Bogner, E. (2003). Identi?cation of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. Nucl. Acids Res., 31, 1426-1433.
245. Secchiero, P., Sun, D., De Vico, A. L. et al. (1997). Role of the extracel-lular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J. Virol., 71, 4571-4580.
246. Sedy, J. R., Gavrieli, M., Potter, K. G. et al. (2005). B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol., 6, 90-98.
247. Silva, M. C., Yu, Q. C., Enquist, L., and Shenk, T. (2003). Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J. Virol., 77, 10594-10605.
248. Silva, M. C., Schroer, J., and Shenk, T. (2005). Human cytomegalovirus cell-to-cell spread in the absence of an essen-tial assembly protein. Proc. Natl Acad. Sci. USA, 102, 2081-2086.
249. Sinzger, C. and Jahn, G. (1996). Human cytomegalovirus cell tropism and pathogenesis. Intervirology, 39, 302-319.
250. Sinzger, C., Kahl, M., Laib, K. et al. (2000). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on ef?cient translocation to the nucleus. J. Gen. Virol., 81, 3021-3035.
251. Sissons, J. G., Bain, M., and Wills, M. R. (2002). Latency and reacti-vation of human cytomegalovirus. J. Infect., 44, 73-77.
252. Skaletskaya, A., Bartle, L. M., Chittenden, T., McCormick, A. L., Mocarski, E. S., and Goldmacher, V. S. (2001). A cytomegalovirus-encoded inhibitor of apoptosis that sup-presses caspase-8 activation. Proc. Natl Acad. Sci. USA, 98, 7829-7834.
253. Smith, J. A., Jairath, S., Crute, J. J., and Pari, G. S. (1996). Char-acterization of the human cytomegalovirus UL105 gene and identi?cation of the putative helicase protein. Virology, 220, 251-255.
254. Spaderna, S., Blessing, H., Bogner, E., Britt, W., and Mach, M. (2002). Identi?cation of glycoprotein gpTRL10 as a structural compo-nent of human cytomegalovirus. J. Virol., 76, 1450-1460.
255. Spaderna, S., Hahn, G., and Mach, M. (2004). Glycoprotein gpTRL10 of human cytomegalovirus is dispensable for virus replication in human ?broblasts. Arch. Virol., 149, 495-506.
256. Spector, D. J. and Tevethia, M. J. (1994). Protein-protein interac-tions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J. Virol., 68, 7549-7553.
257. Spencer, J. V., Lockridge, K. M., Barry, P. A. et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol., 76, 1285-1292.
258. Stamey, F. R., Dominguez, G., Black, J. B., Dambaugh, T. R., and Pel-lett, P. E. (1995). Intragenomic linear ampli?cation of human herpesvirus 6B oriLyt suggests acquisition of oriLyt by trans-position. J. Virol., 69, 589-596.
259. Stamminger, T., Gstaiger, M., Weinzierl, K., Lorz, K., Winkler, M., and Schaffner, W. (2002). Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that con-tains a strong transcriptional activation domain. J. Virol., 76, 4836-4847.
260. Stasiak, P. C. and Mocarski, E. S. (1992). Transactivation of the cytomegalovirus ICP36 gene promoter requires the CY gene product TRS1 in addition to IE1 and IE2. J. Virol., 66, 1050-1058.
261. Stefan, A., Secchiero, P., Baechi, T., Kempf, W., and Campadelli-Fiume, G. (1997). The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles. J. Virol., 71, 5758-5763.
262. Streblow, D. N., Soderberg-Naucler, C., Vieira, J. et al. (1999). The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell, 99, 511-520.
263. Strive, T., Gicklhorn, D., Wohlfahrt, M. et al. (2004). Site directed mutagenesis of the carboxyl terminus of human cytomegalovirus glycoprotein B leads to attenuation of viral growth in cell culture. Arch. Virol.
264. Sun, Y. and Conner, J. (1999). The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit. J. Gen. Virol., 80(10), 2713-2718.
265. Takemoto, M., Shimamoto, T., Isegawa, Y., and Yamanishi, K. (2001). The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J. Virol., 75, 10149-10160.
266. Talarico, C. L., Burnette, T. C., Miller, W. H. et al. (1999). Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob. Agents Chemother., 43, 1941-1946.
267. Taniguchi, T., Shimamoto, T., Isegawa, Y., Kondo, K., and Yamanishi, K. (2000). Structure of transcripts and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells. Virology, 271, 307-320.
268. Terhune, S. S., Schroer, J., and Shenk, T. (2004). RNAs are pack-aged into human cytomegalovirus virions in proportion to their intracellular concentration. J. Virol., 78, 10390-10398.
269. Theiler, R. N. and Compton, T. (2002). Distinct glycoprotein O com-plexes arise in a post-Golgi compartment of cytomegalovirus-infected cells. J. Virol., 76, 2890-2898.
270. Tigue, N. J., Matharu, P. J., Roberts, N. A., Mills, J. S., Kay, J., and Jupp, R. (1996). Cloning, expression and characterization of the proteinase from human herpesvirus 6. J. Virol., 70, 4136-4141.
271. Tirabassi, R. S. and Ploegh, H. L. (2002). The human cytomegalovirus US8 glycoprotein binds to major histo-compatibility complex class I products. J. Virol., 76, 6832-6835.
272. Tirosh, B., Iwakoshi, N. N., Lilley, B. N., Lee, A. H., Glimcher, L. H., and Ploegh, H. L. (2005). Human cytomegalovirus protein US11 provokes an unfolded protein response that may facili-tate the degradation of class I major histocompatibility com-plex products. J. Virol., 79, 2768-2779.
273. Tomasec, P., Braud, V. M., Rickards, C. et al. (2000). Surface expres-sion of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science, 287, 1031-1033.
274. Tomasec, P., Wang, E. C., Davison, A. J. et al. (2005). Downregula-tion of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol., 6, 181-188.
275. Tooze, J., Hollinshead, M., Reis, B., Radsak, K., and Kern, H. (1993). Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol., 60, 163-178.
276. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., and Ploegh, H. L. (2000). Viral subversion of the immune system. Annu. Rev. Immunol., 18, 861-926.
277. Tugizov, S., Navarro, D., Paz, P., Wang, Y., Qadri, I., and Pereira, L. (1994). Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology, 201, 263-276.
278. Ulbrecht, M., Martinozzi, S., Grzeschik, M. et al. (2000). Cutting edge: The human cytomegalovirus UL40 gene product con-tains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol., 164, 5019-5022.
279. Ulbrecht, M., Hofmeister, V., Yuksekdag, G. et al. (2003). HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum. Immunol., 64, 231-237.
280. Vales-Gomez, M., Browne, H., and Reyburn, H. T. (2003). Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells. BMC Immunol., 4, 4.
281. Vales-Gomez, M., Shiroishi, M., Maenaka, K., and Reyburn, H. T. (2005). Genetic variability of the major histocom-patibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J. Virol., 79, 2251-2260
282. Van Loon, N., Dykes, C., Deng, H., Dominguez, G., Nicholas, J., and Dewhurst, S. (1997). Identi?cation and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7. J. Virol., 71, 3279-3284.
283. Varnum, S. M., Streblow, D. N., Monroe, M. E. etal.(2004). Identi?ca-tion of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome. J. Virol., 78, 10960-10966.
284. Vieira, J., Schall, T. J., Corey, L., and Geballe, A. P. (1998). Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green ?uorescent protein gene. J. Virol., 72, 8158-8165.
285. Wang, D., Bresnahan, W., and Shenk, T. (2004a). Human cytomegalovirus encodes a highly speci?c RANTES decoy receptor. Proc. Natl Acad. Sci. USA, 101, 16642-16647.
286. Wang, E. C., McSharry, B., Retiere, C. et al. (2002). UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl Acad. Sci. USA, 99, 7570-7575.
287. Wang, S. K., Duh, C. Y., and Wu, C. W. (2004b). Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication. J. Virol., 78, 9750-9762.
288. Wang, X., Huong, S. M., Chiu, M. L., Raab-Traub, N., and Huang, E. S. (2003). Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature, 424, 456-461.
289. White, E. A., Clark, C. L., Sanchez, V., and Spector, D. H. (2004). Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol., 78, 1817-1830.
290. Willcox, B. E., Thomas, L. M., and Bjorkman, P. J. (2003). Crys-tal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol., 4, 913-919.
291. Wing, B. A. and Huang, E. S. (1995). Analysis and mapping of a family of 3?-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol., 69, 1521-1531.
292. Wing, B. A., Lee, G. C., and Huang, E. S. (1996). The human cytomegalovirus UL94 open reading frame encodes a con-served herpesvirus capsid/tegument-associated virion pro-tein that is expressed with true late kinetics. J. Virol., 70, 3339-3345.
293. Wing, B. A., Johnson, R. A., and Huang, E. S. (1998). Identi?cation of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: Role of IE2-86 and cellular p53 in mediating negative regulatory function. J. Virol., 72, 1814-1825.
294. Wolf, D. G., Honigman, A., Lazarovits, J., Tavor, E., and Panet, A. (1998). Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase. Arch. Virol., 143, 1223-1232.
295. Wolf, D. G., Courcelle, C. T., Prichard, M. N., and Mocarski, E. S. (2001). Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsi-dation. Proc. Natl Acad. Sci. USA, 98, 1895-1900.
296. Wood, L. J., Baxter, M. K., Plafker, S. M., and Gibson, W. (1997). Human cytomegalovirus capsid assembly protein precursor (pUL80.5) interacts with itself and with the major capsid protein (pUL86) through two different domains. J. Virol., 71, 179-190.
297. Xu, Y., Cei, S. A., Huete, A. R., and Pari, G. S. (2004a). Human cytomegalovirus UL84 insertion mutant defective for viral DNA synthesis and growth. J. Virol., 78, 10360-10369.
298. Xu, Y., Cei, S. A., Rodriguez Huete, A., Colletti, K. S., and Pari, G. S. (2004b). Human cytomegalovirus DNA replication requires transcriptional activation via an IE2-and UL84-responsive bidirectional promoter element within oriLyt. J. Virol., 78, 11664-11677.
299. Yoon, J. S., Kim, S. H., Shin, M. C. et al. (2004). Inhibition of herpesvirus-6B RNA replication by short interference RNAs. J. Biochem. Mol. Biol., 37, 383-385.
300. Yu, D., Smith, G. A., Enquist, L. W., and Shenk, T. (2002). Construc-tion of a self-excisable bacterial arti?cial chromosome con-taining the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol., 76, 2316-2328.
301. Yu, D., Silva, M. C., and Shenk, T. (2003). Functional map of human cytomegalovirus AD169 de?ned by global mutational analysis. Proc. Natl Acad. Sci. USA, 100, 12396-12401.
302. Yu, X., Shah, S., Atanasov, I., Lo, P., Liu, F., Britt, W. J., and Zhou, Z. H. (2005). Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid. J. Virol., 79, 1327-1332.
303. Yurochko, A. D. and Huang, E. S. (1999). Human cytomega-lovirus binding to human monocytes induces immun-oregulatory gene expression. J. Immunol., 162, 4806-4816.
304. Yurochko, A. D., Kowalik, T. F., Huong, S. M., and Huang, E. S. (1995). Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol., 69, 5391-5400.
305. Yurochko, A. D., Hwang, E. S., Rasmussen, L., Keay, S., Pereira, L., and Huang, E. S. (1997). The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid acti-vation of Sp1 and NF-kappaB during infection. J. Virol., 71, 5051-5059.
306. Zhao, Y. and Biegalke, B. J. (2003). Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa). Virology, 315, 353-361.
307. Zini, N., Battista, M. C., Santi, S. et al. (1999). The novel structural protein of human cytomegalovirus, pUL25, is localized in the viral tegument. J. Virol., 73, 6073-6075.
308. Zini, N., Santi, S., Riccio, M., Landini, M. P., Battista, M. C., and Maraldi, N. M. (2000). pUL25 immunolocalization in human cytomegalovirus-infected and gene-transfected cells. Arch. Virol., 145, 795-803.
309. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y., and Yamanishi, K. (1999). Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol., 73, 5926-5933.